A Comparison of the Potency of Newly Developed Oximes (K005, K027, K033, K048) and Currently Used Oximes (Pralidoxime, Obidoxime, HI-6) to Reactivate Sarin-Inhibited Rat Brain Acetylcholinesterase By in Vitro Methods

By Kuca Kamil   Cabal Jiri   Kassa Jiri  

Journal of Toxicology and Environmental Health, Vol. 68, Iss. 8, 2005-01 ,pp. : 677-686

Taylor & Francis Ltd

Access to resources Recommend Favorite

Potency of HI-6 to Reactivate Cyclosarin, Soman and Tabun Inhibited Acetylcholinesterase - In Vivo Study

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 7, 2010-08 ,pp. : 516-520

Bentham Science Publishers

Access to resources Recommend Favorite

Twelve Different HI-6 Salts and their Potency to Reactivate Cyclosarin Inhibited AChE In Vitro

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 7, 2007-10 ,pp. : 510-512

Bentham Science Publishers

Access to resources Recommend Favorite

Universality of Oxime K203 for Reactivation of Nerve Agent-Inhibited AChE

By  

Medicinal Chemistry, Vol. 11, Iss. 7, 2015-01 ,pp. : 683-686

Bentham Science Publishers

Access to resources Recommend Favorite

Development of the Bisquaternary Oxime HI-6 Toward Clinical Use in the Treatment of Organophosphate Nerve Agent Poisoning

By Lundy Paul M.  

Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol. 25, Iss. 4, 2006-01 ,pp. : 231-243

Adis International

Access to resources Recommend Favorite